本页面由Tiger Trade Technology Pte. Ltd.提供服务

Centessa Pharmaceuticals plc

39.48
-0.2800-0.70%
盘后39.480.00000.00%16:10 EDT
成交量:126.25万
成交额:5,005.14万
市值:61.02亿
市盈率:-27.04
高:39.77
开:39.76
低:39.47
收:39.76
52周最高:40.26
52周最低:10.87
股本:1.55亿
流通股本:8,933.05万
量比:0.44
换手率:1.41%
股息:- -
股息率:- -
每股收益(TTM):-1.4600
每股收益(LYR):-1.4600
净资产收益率:-42.55%
总资产收益率:-20.53%
市净率:11.58
市盈率(LYR):-27.04

数据加载中...

2024/10/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/09/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

重要事件披露

Form 8-K - Current report
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

重要事件披露

Form 8-K - Current report
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report